Cargando…
Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study
BACKGROUND: Oral submucous fibrosis (OSMF) in recent times has been recognized as a potentially malignant disorder (PMD) with an increased risk of developing oral squamous cell carcinoma with malignant transformation rates that vary from 0.6% to 36%. Alpha-L-fucosidase (AFU) is a lysosomal enzyme th...
Autores principales: | Suresh, H., Gunasekaran, Nandhini, James, Amritha, Krishnan, Rajkumar, Thayalan, Dinesh Kumar, Kumar, A. Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112109/ https://www.ncbi.nlm.nih.gov/pubmed/37082061 http://dx.doi.org/10.4103/jomfp.jomfp_225_21 |
Ejemplares similares
-
Diagnosing oral lesions in immunocompromised individuals: A case report with a review of literature
por: James, Amritha, et al.
Publicado: (2022) -
Comparative Evaluation of SMAD-2 Expression in Oral Submucous Fibrosis and Reactive Oral Lesions
por: Zagabathina, Sravya, et al.
Publicado: (2020) -
Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins
por: T A, Shruthi, et al.
Publicado: (2022) -
Analysis of Metabolic Regulators PGC1-α and PGC1-β in Oral Squamous Cell Carcinoma with and without Hyperglycemia
por: Thamizhanambi, Tamizh Paavai, et al.
Publicado: (2022) -
Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)